Alpha Tribe
FeedCompaniesAgentsSubscribe

Filter announcements

  • All
  • Important
  • Results
  • Board Meeting
  • New Orders
  • QIP/Rights/Pref.
  • PPTs
  • JV/Acquisition
  • Insider Trade
  • Dividend/Bonus
  • Credit Ratings
  • Updates
  • Pledging
  • Investor Meet
  • Others

Download our app

Best experience on mobile

Get it on Google PlayDownload on the App Store

Join 5K+ users on Alpha Tribe

Loading...
Themis Medicare Limited logo

Themis Medicare Limited

THEMISMED·Pharmaceuticals

Themis Medicare is principally engaged in the activities pertaining to manufacturing of pharmaceutical products, especially in Formulation and API activity.

97Announcements
09-09-2026Last filed
17Last 90 days

What Themis files

  • Others53
  • Board Meeting11
  • Important11
  • Updates7
  • PPTs7
  • Pledging3
Showing Important announcements (11)Clear filter
14-01-2026 · 07:07 pm

Themis Medicare's registrar confirmed no requests to re-lodge physical share transfers were received during December.

Read the full announcement→
PDF
29-12-2025 · 07:54 pm

Themis Medicare confirmed zero re-lodgement requests for physical share transfers during the recent two-month window, indicating smooth administrative processing for physical shareholders.

Read the full announcement→
PDF
17-10-2025 · 11:50 am

Themis Medicare reports no requests for re-lodgement of physical share transfers were received during the special compliance window period. This indicates smooth operations with no outstanding physical share transfer issues.

Read the full announcement→
PDF
09-10-2025 · 06:56 pm

Themis Medicare is supporting the 'Saksham Niveshak' campaign, urging shareholders to update KYC details and bank mandates. This initiative aims to help shareholders claim their unpaid/unclaimed dividends.

Read the full announcement→
PDF
13-06-2025 · 07:26 pm

Themis Medicare and its subsidiary Gujarat Themis Biosyn have called off their merger plan. Gujarat Themis Biosyn will now focus on boosting its fermentation-based pharma intermediates and API business via capacity expansion and partnerships. Meanwhile, Themis Medicare will prioritize strengthening its core domestic formulations segment for steady growth. This strategic...

Read the full announcement→
PDF